Einrichtungen, die zum Universitätsklinikum Erlangen gehören

No evidence for exosome treatment in reducing alcohol relapse – a failed confirmatory multi-center study (2025) Meinhardt MW, Habelt B, Skorodumov I, Schwarz C, Bernhardt N, Winter C, Hardar R, et al. Journal article Contrast-enhanced multispectral optoacoustic tomography for the assessment of the gastrointestinal transit in patients with cystic fibrosis (2025) Fuchte J, Wachter F, Claßen M, Vogt-Wolz H, Paulus LP, Mandelbaum H, Buehler A, et al. Journal article Four eyes principle reduces re-operation rate in converting phase from open to laparoscopic pyloromyotomy (2025) Meyer J, Spacil K, Stehr M, Schäfer FM Journal article Micrometastasis and Isolated Tumor Cells in Oral Squamous Cell Carcinoma: Refining Nodal Staging with Emerging Technologies (2025) MP S, Rao KN, Thompson LD, Rodrigo JP, de Bree R, Stenman G, Schilling C, et al. Journal article, Review article TROP-2 overexpression in papillary renal cell carcinoma supports its potential as a therapeutic target for antibody-drug-conjugate therapy (2025) Kessler C, von Brandenstein M, Klümper N, Krausewitz P, Storz E, Rieger C, Sperber L, et al. Journal article TriCAM (NCT02976558) – a randomized controlled pilot study of complementary medicine in allogeneic stem cell transplantation to improve quality of life (2025) Behzad A, Krause S, Mackensen A, Müller F, Stark A, Völkl S, Rösler W Journal article Recombinant cathepsins B and L promote α-synuclein clearance and restore lysosomal function in human and murine models with α-synuclein pathology (2025) Balta D, Varghese A, Prieto Huarcaya S, Di Spiezio A, Marques AR, Akdas EY, Tabakacilar D, et al. Journal article Inhibiting the DNA damage repair of HNSCC cells in combination with normo-fractionated radiotherapy influences clonogenicity, senescence and expression of NK cell activation markers (2025) Jost T, Wachter M, Meidenbauer J, Fietkau R, Gaipl U Journal article Letter: Updates to Microhematuria: AUA/SUFU Guideline (2025) (2025) Shariat SF, Van Rhijn BW, Bolenz C, Witjes JA, Burger M, Schmitz-Dräger BJ Journal article A randomized, controlled, 12-month trial on the effects of an interdisciplinary treatment approach in ESRD patients: study protocol of the smart and fit for kidney transplantation trial (S&F4KTx) (2025) Krusemark H, Kleemann J, Weigand J, Kannenkeril D, Heller KM, Hepp T, Albersmeyer M, et al. Journal article